Single Dose Escalation Study of GSK2838232 in Healthy Subjects

Clinical trial NCT01802918 · COMPLETED

Trial details

NCT number: NCT01802918
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Infection, Human Immunodeficiency Virus

Start date: 2013-02-18
Primary completion: 2013-11-21
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.